Affidea forms AI partnership with Icometrix

By staff writers

March 6, 2019 -- Diagnostic imaging, outpatient, and cancer care services provider Affidea Group is teaming with Belgian software company Icometrix to improve care for patients with multiple sclerosis (MS) and other neurological disorders using artificial intelligence (AI).

Icometrix's icobrain AI software is designed to help radiologists and neurologists quantify and track different brain abnormalities on MRI scans. Information is presented in a report that includes healthy control data to aid in the interpretation and communication of results.

Affidea will implement a new AI tool, known as icobrainms, to monitor disease progression and help assess MS patients to improve their treatment and follow-up care.

The pilot program will launch in Italy, Portugal, Switzerland, and Serbia.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking